Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson’s disease

Parkinson disease and the immune system — associations, mechanisms and therapeutics

(2020) Eng-King Tan et al.   Nature Reviews Neurology

Autoimmune glial fibrillary acidic protein astrocytopathy

(2019) Amy Kunchok et al.   CURRENT OPINION IN NEUROLOGY

A case of GFAP-astroglial autoimmunity presenting with reversible parkinsonism

(2019) Anna Tomczak et al.   Multiple Sclerosis and Related Disorders

Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Review of the Literature

(2018) Fulan Shan et al.   Frontiers in Immunology

Plasma Anti-Glial Fibrillary Acidic Protein Autoantibody Levels during the Acute and Chronic Phases of Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot Study

(2016) Kevin K. W. Wang et al.   JOURNAL OF NEUROTRAUMA

Human Traumatic Brain Injury Induces Autoantibody Response against Glial Fibrillary Acidic Protein and Its Breakdown Products

(2014) Zhiqun Zhang et al.   PLoS One

Immunology, Autoimmunity, and Autoantibodies in Parkinson’s Disease

(2011) Michal Benkler et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Subsequent Risks of Parkinson Disease in Patients with Autoimmune and Related Disorders: A Nationwide Epidemiological Study from Sweden

(2011) Xinjun Li et al.   Neurodegenerative Diseases

Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood–brain barrier breakdown

(2010) Eli C. Levin et al.   BRAIN RESEARCH

Anti-melanin antibodies are increased in sera in Parkinson's disease

(2009) K.L. Double et al.   EXPERIMENTAL NEUROLOGY